An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading ->
Policy leaders must redesign global economic incentives to advance healthy diets, and take a harder line against commercial interests promoting excessive production and consumption of unhealthy foods. Current trends are driving the inter-related pandemics of obesity and undernutrition as well as climate change, according to a new report by The Lancet Commission on Obesity. Continue reading ->